drugset / Trial / NCT06473662
Study to Evaluate the Safety and Efficacy of Oral Insulin Formulation in Type 2 Diabetes Mellitus Subjects
RandomizedParallel-groupOpen-labelTreatment
Summary
The aim of the study was to compare the pharmacodynamic properties of different doses of regular human insulin administered in capsule form twice daily in a randomised twelve-week open-label trial.
Timeline
- Start
- 2018-10-22
- Primary completion
- 2020-07-11
- Completion
- 2020-07-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Insulin | Protein / enzyme biologic | 75 iu | Oral |
| Subject | Insulin | Protein / enzyme biologic | 150 iu | Oral |
| Subject | Insulin | Protein / enzyme biologic | 300 iu | Oral |